WW INTERNATIONAL, INC.
Close on Oct 19, 2026
- Market cap
- $127.51M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 5, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 5, 2026 | After market close | $162.30M | $1.41 | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | Before market open | $168.00M | $-5.20 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 16, 2026 | Before market open | $163.00M | $-0.58 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | Before market open | $172.09M | $-5.76 | – |
| Q2 FY2025 Ended Jun 24, 2025 | Aug 11, 2025 | Before market open | $189.00M | $0.13 | – |
| Q1 FY2025 Ended Mar 29, 2025 | May 6, 2025 | After market close | $186.60M | $-0.91 | $-0.47 |
| Q4 FY2024 Ended Dec 28, 2024 | Feb 27, 2025 | After market close | $184.40M | $0.31 | $0.32 |
| Q3 FY2024 Ended Sep 28, 2024 | Nov 6, 2024 | Before market open | $192.90M | $-0.58 | $0.24 |
| Q2 FY2024 Ended Jun 29, 2024 | Aug 1, 2024 | Before market open | – | – | – |
| Q1 FY2024 Ended Mar 30, 2024 | May 2, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 30, 2023 | Feb 28, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Aug 5, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDA guidancenon-GAAP | year ending December 31, 2026 | $105.00M to $115.00M | Maintained |
| Revenue guidance | year ending December 31, 2026 | $620.00M to $635.00M | Maintained |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Ww International filed with the SEC
Weight Watchers Appoints Stephen Bye as Chief Executive Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Weight Watchers Announces Second Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
WATCH IT WORK Q2 2026 Shareholder Letter August 5 2026 Weight watch
Results of operations · EX-99.2 to Form 8-K
Weight Watchers Announces First Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
Business Update Building Integrated Weight Health Platform: Continuing to execute on our strategy to provide industry-leading weight
Results of operations · EX-99.2 to Form 8-K
Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt
Regulation FD disclosure · EX-99.1 to Form 8-K
Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Weight Watchers Announces Board Committee Appointments
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K/A
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Weight Watchers Announces Fourth Quarter and Full Year 2025 Results
Results of operations · EX-99.1 to Form 8-K
Q4 2025 Shareholder Letter MARCH 16 2026 WEIGHT WATCHERS LESLEY MENOPAUSE MARIA MED+ CODY GLP-1SUCCESS PALMER POINTS CHERIA
Results of operations · EX-99.2 to Form 8-K
WeightWatchers Announces Third Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
Q3 2025 Shareholder Letter November 6, 2025 Keenan S. -130 lb*
Results of operations · EX-99.2 to Form 8-K
WeightWatchers Announces Second Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
Q2 2025 Shareholder Letter August 11, 2025
Results of operations · EX-99.2 to Form 8-K
STRENGTHENS LEADERSHIP, AND EXPANDS PROGRAM INNOVATION TO
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
WeightWatchers Reorganization Plan Confirmed, Clears Path for Elimination of Majority of Legacy Debt Burden and Execution of Transformation Plan
Bankruptcy · Regulation FD disclosure · EX-99.1 to Form 8-K
IN THE UNITED STATES BANKRUPTCY COURT
Material agreement · Bankruptcy · Regulation FD disclosure · EX-99.1 to Form 8-K
WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of Debt, Strengthening Financial
Material agreement · Bankruptcy · Regulation FD disclosure · EX-99.2 to Form 8-K
Disclaimer This presentation (this “Presentation”) is being
Material agreement · Bankruptcy · Regulation FD disclosure · EX-99.3 to Form 8-K
WW International, Inc. Announces First Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
WW International, Inc. Announces Fourth Quarter and Full Year 2024 Results
Results of operations · EX-99.1 to Form 8-K
WW International, Inc. Announces CFO Transition
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
John Mills or Anna Kate Heller
Results of operations · EX-99.1 to Form 8-K
Independent Board Member Tara Comonte Will Serve as Interim Chief Executive Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
WW International, Inc. Announces Second Quarter 2024 Results
Results of operations · Exit or restructuring costs · Executive or director change · EX-99.1 to Form 8-K
WW International, Inc. Announces First
Results of operations · EX-99.1 to Form 8-K/A
WW International, Inc. Announces First
Results of operations · EX-99.1 to Form 8-K
WW International, Inc. Announces Fourth Quarter and Full Year 2023 Results
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
WW International, Inc. Announces Upcoming Oprah Winfrey Board Transition
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
WW International, Inc. Announces Third Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
William Shrank, MD, Former Chief Medical Officer at Humana, to Join WW International, Inc. Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
WW International, Inc. Announces Second Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
2022-12-31 http://fasb.org/us-gaap/2023#Assets http://fasb.org/us-gaap/2023#AssetImpairmentCharges http://fasb.org/us-gaap/2023#AssetImpairmentCharges http://fasb.org/us-gaap/2023#AssetImpairmentCharges http://fasb.org/us-gaap/2023#AssetImpairmentCharges http://fasb.org/us-gaap/2023#AssetImpairme…
Other events · EX-99.1 to Form 8-K
Tara Comonte, CEO TMRW Life Sciences, to Join WW International, Inc. Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
WW International, Inc. Announces First Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
WW International, Inc. Completes Acquisition of Sequence
Acquisition or disposition completed · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
WW International, Inc. Announces Upcoming Changes to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
WW International, Inc. Announces Fourth Quarter and Full Year 2022 Results
Material agreement · Results of operations · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
WeightWatchers to Acquire Sequence, a Digital Health Platform for Clinical Weight Management
Material agreement · Results of operations · Unregistered share sale · Regulation FD disclosure · EX-99.2 to Form 8-K